Skip to main content

Learn about membership types and categories.

Leadership

  • Eligibility for appointment as HCI Program Leader (Type 1)
  • Eligibility for appointment as HCI Translational Scholar (Type 1)
  • Eligibility for inclusion in HCI strategic planning (Type 1, 2)
  • Opportunity to provide input on Program and Shared Resource development (Type 1, 2)

Institutional Funding Opportunities

  • Program Funding
    • Pilot Research
      • Projects including both Type 1 and Type 2 members, with a mentoring component.
      • Collaborative projects involving multiple Type 1 members
      • Single PI projects led by a Type 1 member
    • Travel funding (Type 1, 2)
  • Center for Investigational Therapeutics
    • Project Funding
      • Projects including both Type 1 and Type 2 members, with a mentoring component.
      • Collaborative projects involving multiple Type 1 members
      • Single PI projects led by a Type 1 member
  • Eligibility to apply for NCI CCSG Supplement funding (Type 1, 2)

Information and Community

  • Receipt of information regarding external funding opportunities (All)
  • Receipt of the HCI newsletter; direct notification of Cancer Center seminars and activities (All)
  • Opportunities to interact with cancer research-oriented colleagues via HCI retreats, symposia, seminars, and meetings (All)
  • Designation as an HCI Investigator (All)

Scientific and Administrative Support

  • Access to HCI-managed Shared Resources (All)
  • Access to interventional clinical research support (All)

Membership Responsibilities

All members are expected to:

  • Participate in Cancer Center activities, such as collaborative research projects and/or clinical trials, meetings, seminars, and retreats
  • Respond to requests for information on research progress, ‘other support pages’, publications, extramural funding, trainees, and biosketches with timely and accurate submissions
  • Acknowledge the Cancer Center Support Grant in publications where appropriate; for details please see Citing the CCSG and HCF Instructions
  • Grant HCI Administration access to funding information provided by PeopleSoft Management Reports

Cancer Center Director

Cornelia Ulrich, MS, PhD

HCI Senior Directors

Neeraj Agarwal, MD
Clinical Research Innovation
Donald E. Ayer, PhD
Cancer Training and Career Enhancement
Max Loveless, MBA
Senior Administrative Director
Martin McMahon, PhD
Preclinical Translation
Kolawole S. Okuyemi, MD, MPH
Equity, Diversity, and Inclusion
Tracy Onega, PhD, MS
Population Sciences
Community Outreach and Engagement (Interim)
Aik Choon Tan, PhD
Data Science
Alana Welm, PhD
Basic Science
Theresa Werner, MD
Clinical Research

Program Leadership

Nuclear Control of Cell Growth and Differentiation

Jay Gertz, PhD
Co-Leader
Jared Rutter, PhD
Co-Leader

Cell Response and Regulation

Sheri Holmen, PhD
Co-Leader

Experimental Therapeutics

Howard Colman, MD, PhD
Co-Leader
Martin McMahon, PhD
Co-Leader

Cancer Control and Population Sciences

Jennifer Doherty, MS, PhD
Co-Leader
Kathleen Mooney, PhD
Co-Leader